Fig. 1From: Insights into the angiogenic effects of nanomaterials: mechanisms involved and potential applicationsReprinted with permission from [50]. Copyright 2015 American Chemical SocietyThe therapeutic efficacy of the MSC or MSC-GO injected into the infarcted myocardium. a MSC adhesion to GO flakes avoids ROS-mediated deterioration in cell adhesion. b Microvessel density in the infarcted region 14 days after MSC or MSC-GO implantation. c Enhanced cardiac repair by MSC-GO implantation.Back to article page